imatinib mesylate has been researched along with Neoplasms, Germ Cell and Embryonal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirotab, S; Kitamura, Y | 1 |
| Brames, MJ; Corless, CL; Einhorn, LH; Heinrich, MC; Madani, A | 1 |
1 review(s) available for imatinib mesylate and Neoplasms, Germ Cell and Embryonal
| Article | Year |
|---|---|
Kit as a human oncogenic tyrosine kinase.
Topics: Animals; Benzamides; Dimerization; Gastrointestinal Stromal Tumors; Homozygote; Humans; Imatinib Mesylate; Leukemia, Mast-Cell; Mice; Models, Biological; Mutation; Neoplasms; Neoplasms, Germ Cell and Embryonal; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Rats; Signal Transduction; Structure-Activity Relationship | 2004 |
1 trial(s) available for imatinib mesylate and Neoplasms, Germ Cell and Embryonal
| Article | Year |
|---|---|
Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.
Topics: Adult; Antineoplastic Agents; Benzamides; Disease Progression; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2006 |